Noom Members Regained 3x Less Weight After Stopping GLP-1s vs Standard-of-Care, New Analyses Show

▤ Summary

Noom announced new observational analyses showing that members in its GLP-1-supported programs regained substantially less weight after stopping medication than published benchmarks. The company says modeled weight gain stayed under 2% of body weight over 12 months and that continued habit use was linked to better maintenance. Noom frames the results as evidence that behavior support can help people keep more of their progress after GLP-1 discontinuation. The announcement also outlines the sample sizes, methodology, and study limitations, including the fact that the analyses were observational and not randomized trials.

▦ Linked Companies